Reason for request
Inclusion
Clinical Benefit
| Moderate |
Moderate AB pending re-assessment of oral antihistamines. |
Clinical Added Value
| no clinical added value |
No improvement in actual benefit (IAB V) compared with other oral H1 antihistamines available in oral form. |
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
21tpjTvysFNJqeyk
Listen
